KEGG   PATHWAY: myb04510
Entry
myb04510                    Pathway                                
Name
Focal adhesion - Myotis brandtii (Brandt's bat)
Description
Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the cell-extracellular matrix contact points, specialized structures are formed and termed focal adhesions, where bundles of actin filaments are anchored to transmembrane receptors of the integrin family through a multi-molecular complex of junctional plaque proteins. Some of the constituents of focal adhesions participate in the structural link between membrane receptors and the actin cytoskeleton, while others are signalling molecules, including different protein kinases and phosphatases, their substrates, and various adapter proteins. Integrin signaling is dependent upon the non-receptor tyrosine kinase activities of the FAK and src proteins as well as the adaptor protein functions of FAK, src and Shc to initiate downstream signaling events. These signalling events culminate in reorganization of the actin cytoskeleton; a prerequisite for changes in cell shape and motility, and gene expression. Similar morphological alterations and modulation of gene expression are initiated by the binding of growth factors to their respective receptors, emphasizing the considerable crosstalk between adhesion- and growth factor-mediated signalling.
Class
Cellular Processes; Cellular community - eukaryotes
Pathway map
myb04510  Focal adhesion
myb04510

Other DBs
GO: 0005925
Organism
Myotis brandtii (Brandt's bat) [GN:myb]
Gene
102238831  PARVG; parvin gamma [KO:K06275]
102239285  SHC4; SHC adaptor protein 4 [KO:K17449]
102239479  BAD; BCL2 associated agonist of cell death [KO:K02158]
102239511  PDGFB; platelet derived growth factor subunit B [KO:K17386]
102239669  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
102239740  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
102239844  CAV3; caveolin 3 [KO:K12959]
102239987  [KO:K04393]
102239988  RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO:K07860]
102240228  CAPN2; calpain-2 catalytic subunit [KO:K03853] [EC:3.4.22.53]
102240259  PDGFD; platelet derived growth factor D [KO:K05450]
102240321  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]
102240345  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]
102240493  LAMC1; laminin subunit gamma 1 [KO:K05635]
102240544  ELK1; ELK1, ETS transcription factor [KO:K04375]
102240696  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
102240943  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]
102241145  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
102241248  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]
102241550  CHAD; chondroadherin [KO:K06248]
102241832  GRB2; growth factor receptor bound protein 2 [KO:K04364]
102242014  ITGB3; integrin subunit beta 3 [KO:K06493]
102242302  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
102242321  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
102242343  TLN1; talin 1 [KO:K06271]
102242389  THBS2; thrombospondin 2 [KO:K04659]
102242492  RASGRF1; Ras protein specific guanine nucleotide releasing factor 1 [KO:K04349]
102242533  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]
102242641  COL4A6; collagen type IV alpha 6 chain [KO:K06237]
102242829  MYLPF; myosin light chain, phosphorylatable, fast skeletal muscle [KO:K12758]
102242832  ITGA11; integrin subunit alpha 11 [KO:K06587]
102243033  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
102243042  PGF; placental growth factor [KO:K16859]
102243136  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
102243369  [KO:K12755]
102243536  COL4A2; collagen type IV alpha 2 chain [KO:K06237]
102243552  COL9A2; collagen type IX alpha 2 chain [KO:K08131]
102244214  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
102244301  LAMA4; laminin subunit alpha 4 [KO:K06241]
102244315  RHOA; ras homolog family member A [KO:K04513]
102244336  ITGA2; integrin subunit alpha 2 [KO:K06481]
102244433  EMP2; epithelial membrane protein 2 [KO:K26256]
102244559  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
102244635  ITGA1; integrin subunit alpha 1 [KO:K06480]
102244665  VTN; vitronectin [KO:K06251]
102244892  FN1; fibronectin 1 [KO:K05717]
102244912  FLT4; fms related tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]
102245080  ARHGAP5; Rho GTPase activating protein 5 [KO:K13709]
102245416  TNR; tenascin R [KO:K06252]
102245460  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
102245599  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]
102245641  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
102245715  ITGA3; integrin subunit alpha 3 [KO:K06482]
102245794  SPP1; secreted phosphoprotein 1 [KO:K06250]
102245860  ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]
102245872  COL6A2; collagen type VI alpha 2 chain [KO:K06238]
102245916  SHC1; SHC adaptor protein 1 [KO:K06279]
102245983  SHC3; SHC adaptor protein 3 [KO:K17448]
102246292  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
102246659  ITGB8; integrin subunit beta 8 [KO:K06591]
102246972  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]
102247194  ACTN1; actinin alpha 1 [KO:K05699]
102247542  [KO:K05096] [EC:2.7.10.1]
102247553  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
102247805  MYL7; myosin light chain 7 [KO:K12754]
102248014  DOCK1; dedicator of cytokinesis 1 [KO:K13708]
102248130  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]
102248184  THBS4; thrombospondin 4 [KO:K04659]
102248306  [KO:K06585]
102248314  COL4A3; collagen type IV alpha 3 chain [KO:K06237]
102248385  PDGFC; platelet derived growth factor C [KO:K05450]
102248413  VCL; vinculin [KO:K05700]
102248545  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
102248597  BCL2; BCL2, apoptosis regulator [KO:K02161]
102248658  VWF; von Willebrand factor [KO:K03900]
102248665  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]
102248758  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
102248763  [KO:K19719]
102249275  ITGB6; integrin subunit beta 6 [KO:K06589]
102249405  COL4A4; collagen type IV alpha 4 chain [KO:K06237]
102249503  RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) [KO:K07861]
102249508  COL4A1; collagen type IV alpha 1 chain [KO:K06237]
102249647  PARVA; parvin alpha [KO:K06275]
102249761  ITGA7; integrin subunit alpha 7 [KO:K06583]
102249845  COMP; cartilage oligomeric matrix protein [KO:K04659]
102249897  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
102249993  RAPGEF1; Rap guanine nucleotide exchange factor 1 [KO:K06277]
102250137  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]
102250383  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]
102250634  THBS3; thrombospondin 3 [KO:K04659]
102250776  MYL10; myosin light chain 10 [KO:K12756]
102250785  ACTN4; actinin alpha 4 [KO:K05699]
102250915  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]
102250973  LAMB1; laminin subunit beta 1 [KO:K05636]
102250983  THBS1; thrombospondin 1 [KO:K16857]
102251030  [KO:K05692]
102251050  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
102251267  COL6A1; collagen type VI alpha 1 chain [KO:K06238]
102251278  DIAPH1; diaphanous related formin 1 [KO:K05740]
102251306  COL9A3; collagen type IX alpha 3 chain [KO:K08131]
102251380  ZYX; zyxin [KO:K06273]
102251394  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]
102251506  SHC2; SHC adaptor protein 2 [KO:K17447]
102251547  LAMB4; laminin subunit beta 4 [KO:K06245]
102251806  [KO:K12755]
102251863  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]
102252071  IGF1; insulin like growth factor 1 [KO:K05459]
102252136  VEGFC; vascular endothelial growth factor C [KO:K05449]
102252301  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
102252389  CCND3; cyclin D3 [KO:K10152]
102252550  TNC; tenascin C [KO:K06252]
102252569  RELN; reelin [KO:K06249] [EC:3.4.21.-]
102252742  TLN2; talin 2 [KO:K06271]
102252747  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]
102252761  ITGA2B; integrin subunit alpha 2b [KO:K06476]
102252849  CTNNB1; catenin beta 1 [KO:K02105]
102252921  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
102252934  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]
102253195  [KO:K04438]
102253405  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
102253516  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
102253526  ITGA8; integrin subunit alpha 8 [KO:K06584]
102253551  PDGFA; platelet derived growth factor subunit A [KO:K04359]
102253559  [KO:K06269] [EC:3.1.3.16]
102253658  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
102253855  TNXB; tenascin XB [KO:K06252]
102253918  COL1A2; collagen type I alpha 2 chain [KO:K06236]
102253973  PXN; paxillin [KO:K05760]
102253999  MYL9; myosin light chain 9 [KO:K12755]
102254003  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
102254069  [KO:K06236]
102254080  COL6A6; collagen type VI alpha 6 chain [KO:K06238]
102254191  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
102254218  CCND2; cyclin D2 [KO:K10151]
102254357  VEGFA; vascular endothelial growth factor A [KO:K05448]
102254720  COL2A1; collagen type II alpha 1 chain [KO:K19719]
102254781  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]
102254864  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
102254910  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
102255250  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
102255293  FLNB; filamin-B [KO:K27392]
102255326  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
102255410  LAMA3; laminin subunit alpha 3 [KO:K06240]
102255770  COL6A5; collagen type VI alpha 5 chain [KO:K06238]
102255900  ITGA5; integrin subunit alpha 5 [KO:K06484]
102256058  LAMC3; laminin subunit gamma 3 [KO:K06247]
102256069  [KO:K06238]
102256140  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]
102256202  LAMA1; laminin subunit alpha 1 [KO:K05637]
102256245  ACTB; actin beta [KO:K05692]
102256265  BCAR1; BCAR1, Cas family scaffolding protein [KO:K05726]
102256358  LAMC2; laminin subunit gamma 2 [KO:K06246]
102256520  [KO:K06240]
102256532  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
102256586  MYL5; myosin light chain 5 [KO:K12753]
102256779  COL4A5; collagen type IV alpha 5 chain [KO:K06237]
102256918  IBSP; integrin binding sialoprotein [KO:K06253]
102257260  CDC42; cell division cycle 42 [KO:K04393]
102257492  VEGFB; vascular endothelial growth factor B [KO:K16858]
102257758  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
102257789  COL6A3; collagen type VI alpha 3 chain [KO:K06238]
102257802  FLNA; filamin A [KO:K04437]
102257812  MYL12B; myosin regulatory light chain 12B [KO:K12757]
102257838  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
102258028  [KO:K06590]
102258119  [KO:K12757]
102258165  LAMB3; laminin subunit beta 3 [KO:K06244]
102258260  MYL2; myosin light chain 2 [KO:K10351]
102258333  [KO:K06590]
102258430  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
102258522  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]
102258771  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
102258809  LAMB2; laminin subunit beta 2 [KO:K06243]
102258848  COL9A1; collagen type IX alpha 1 chain [KO:K08131]
102259160  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
102259408  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
102259449  HGF; hepatocyte growth factor [KO:K05460]
102259547  ITGA4; integrin subunit alpha 4 [KO:K06483]
102259707  COL1A1; collagen type I alpha 1 chain [KO:K06236]
102259949  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]
102259984  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
102260193  ITGA10; integrin subunit alpha 10 [KO:K06586]
102260390  ITGB4; integrin subunit beta 4 [KO:K06525]
102260401  ITGAV; integrin subunit alpha V [KO:K06487]
102260487  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
102260557  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
102260639  VEGFD; vascular endothelial growth factor D [KO:K05449]
102260644  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
102260808  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
102260978  ITGB1; integrin subunit beta 1 [KO:K05719]
102261163  VASP; vasodilator-stimulated phosphoprotein [KO:K06274]
102261192  TNN; tenascin N [KO:K06252]
102261526  LAMA2; laminin subunit alpha 2 [KO:K05637]
102261636  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]
102261916  ITGA6; integrin subunit alpha 6 [KO:K06485]
102262191  ITGB5; integrin subunit beta 5 [KO:K06588]
102262391  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
102262704  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]
102263001  EMP1; epithelial membrane protein 1 [KO:K26255]
102263026  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
102263347  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
102263484  CCND1; cyclin D1 [KO:K04503]
102263523  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
102263592  ACTG1; actin gamma 1 [KO:K05692]
102263659  CAV1; caveolin 1 [KO:K06278]
102263667  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
102263709  LAMA5; laminin subunit alpha 5 [KO:K06240]
102263913  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]
102264168  CAV2; caveolin 2 [KO:K12958]
102264183  PARVB; parvin beta [KO:K06275]
102264252  EGF; epidermal growth factor [KO:K04357]
Compound
C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Berman AE, Kozlova NI, Morozevich GE.
  Title
Integrins: structure and signaling.
  Journal
Biochemistry (Mosc) 68:1284-99 (2003)
DOI:10.1023/b:biry.0000011649.03634.74
Reference
  Authors
Lee JW, Juliano R.
  Title
Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways.
  Journal
Mol Cells 17:188-202 (2004)
Reference
  Authors
Danen EH, Yamada KM.
  Title
Fibronectin, integrins, and growth control.
  Journal
J Cell Physiol 189:1-13 (2001)
DOI:10.1002/jcp.1137
Reference
  Authors
Guo W, Giancotti FG.
  Title
Integrin signalling during tumour progression.
  Journal
Nat Rev Mol Cell Biol 5:816-26 (2004)
DOI:10.1038/nrm1490
Reference
  Authors
Petit V, Thiery JP.
  Title
Focal adhesions: structure and dynamics.
  Journal
Biol Cell 92:477-94 (2000)
DOI:10.1016/S0248-4900(00)01101-1
Reference
  Authors
Stupack DG, Cheresh DA.
  Title
Get a ligand, get a life: integrins, signaling and cell survival.
  Journal
J Cell Sci 115:3729-38 (2002)
DOI:10.1242/jcs.00071
Reference
  Authors
Parsons JT.
  Title
Focal adhesion kinase: the first ten years.
  Journal
J Cell Sci 116:1409-16 (2003)
DOI:10.1242/jcs.00373
Reference
  Authors
Mitra SK, Hanson DA, Schlaepfer DD.
  Title
Focal adhesion kinase: in command and control of cell motility.
  Journal
Nat Rev Mol Cell Biol 6:56-68 (2005)
DOI:10.1038/nrm1549
Reference
  Authors
Comoglio PM, Boccaccio C, Trusolino L.
  Title
Interactions between growth factor receptors and adhesion molecules: breaking the rules.
  Journal
Curr Opin Cell Biol 15:565-71 (2003)
DOI:10.1016/S0955-0674(03)00096-6
Reference
  Authors
Schlaepfer DD, Mitra SK.
  Title
Multiple connections link FAK to cell motility and invasion.
  Journal
Curr Opin Genet Dev 14:92-101 (2004)
DOI:10.1016/j.gde.2003.12.002
Reference
  Authors
Burridge K, Wennerberg K.
  Title
Rho and Rac take center stage.
  Journal
Cell 116:167-79 (2004)
DOI:10.1016/S0092-8674(04)00003-0
Reference
  Authors
Schmitz AA, Govek EE, Bottner B, Van Aelst L.
  Title
Rho GTPases: signaling, migration, and invasion.
  Journal
Exp Cell Res 261:1-12 (2000)
DOI:10.1006/excr.2000.5049
Reference
  Authors
Vanhaesebroeck B, Alessi DR.
  Title
The PI3K-PDK1 connection: more than just a road to PKB.
  Journal
Biochem J 346 Pt 3:561-76 (2000)
DOI:10.1042/bj3460561
Reference
  Authors
Nicholson KM, Anderson NG.
  Title
The protein kinase B/Akt signalling pathway in human malignancy.
  Journal
Cell Signal 14:381-95 (2002)
DOI:10.1016/S0898-6568(01)00271-6
Reference
  Authors
Oloumi A, McPhee T, Dedhar S.
  Title
Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.
  Journal
Biochim Biophys Acta 1691:1-15 (2004)
DOI:10.1016/j.bbamcr.2003.12.002
Reference
  Authors
Turner CE.
  Title
Paxillin and focal adhesion signalling.
  Journal
Nat Cell Biol 2:E231-6 (2000)
DOI:10.1038/35046659
Reference
  Authors
Hlobilkova A, Knillova J, Bartek J, Lukas J, Kolar Z.
  Title
The mechanism of action of the tumour suppressor gene PTEN.
  Journal
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147:19-25 (2003)
Related
pathway
myb04010  MAPK signaling pathway
myb04060  Cytokine-cytokine receptor interaction
myb04070  Phosphatidylinositol signaling system
myb04110  Cell cycle
myb04151  PI3K-Akt signaling pathway
myb04310  Wnt signaling pathway
myb04512  ECM-receptor interaction
myb04810  Regulation of actin cytoskeleton
KO pathway
ko04510   

DBGET integrated database retrieval system